SCHEMBL7469182

SCHEMBL7469182

CCCc1[nH]c2c(C(=O)OC)cccc2c1C(=O)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
HSD17B10 Q99714 1/20 0.47
PIM1 P11309 2/20 0.44
PIM3 Q86V86 2/20 0.44
NR4A2 P43354 3/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
GSK3B P49841 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
CLEC4M Q9H2X3 1/20 0.38
CREBBP Q92793 1/20 0.37
ELANE P08246 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7410219 0.89 LMNA (0.49) LMNAL3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL8621598 0.86 LMNA (0.47) LMNAL3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL7410235 0.81 LMNA (0.44) LMNAL3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL7411523 0.80 OXER1 (0.44) LMNAL3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL7412570 0.78 LMNA (0.48) LMNAL3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL7422800 0.74 KMT2A (0.58) L3MBTL1ALDH1A1KDM4EHPGDHTT
SCHEMBL7470065 0.74 MEN1 (0.68) L3MBTL1ALDH1A1MAPTKDM4EHPGD
SCHEMBL7407743 0.73 NR4A2 (0.44) LMNAL3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL7707705 0.73 SMN1; SMN2 (0.42) LMNAL3MBTL1ALDH1A1MAPTKDM4E
SCHEMBL7707708 0.70 KMT2A (0.41) LMNAL3MBTL1ALDH1A1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed